<DOC>
	<DOCNO>NCT00448058</DOCNO>
	<brief_summary>To evaluate efficacy , safety , tolerability GSK372475 compare placebo treatment outpatient subject Major Depressive Disorder ( MDD )</brief_summary>
	<brief_title>A Study Of New Medicine ( GSK 372475 ) For The Treatment Of Depression</brief_title>
	<detailed_description>A Ten-Week , Multicenter , Randomized , Double-Blind , Placebo Active-Controlled , Parallel-Group , Flexible-Dose Study Evaluating Efficacy , Safety , Tolerability GSK372475 ( 1.5 mg/day 2.0 mg/day ) Extended Release Venlafaxine XR ( 150 mg/day 225 mg/day ) Compared Placebo Adult Subjects Diagnosed Major Depressive Disorder</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Major depressive episode ( MDE ) associate Major Depressive Disorder ( DSMIVTR criterion ) Duration current episode least 12 week duration le 2 year Symptoms decrease energy , pleasure , interest Female subject agree use acceptable method birth control throughout study Exclusion criterion : Current diagnosis Panic Disorder , symptom generalize anxiety panic attack could interfere ability complete trial Symptoms MDE well account another diagnosis Diagnosis Bipolar , schizophrenia , psychotic disorder ( ) , borderline antisocial personality disorder , dementia . Started psychotherapy within 3 month prior Screening Received electroconvulsive therapy transcranial magnetic stimulation within 6 month prior screen Received psychoactive drug within 4 week randomization Positive urine drug screen positive blood alcohol Suicidal risk previous suicide attempt , family history suicide attempt Positive pregnancy test History seizure disorder , myocardial infarction ( &lt; 1yr ) , unstable medical condition Failed respond adequate course pharmacotherapy least 2 different antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Flexible-dose</keyword>
	<keyword>GSK372475</keyword>
	<keyword>MDD</keyword>
	<keyword>Venlafaxine XR</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>